SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: Anthony Wong who wrote (4858)8/12/1998 5:49:00 AM
From: Anthony Wong  Read Replies (2) | Respond to of 9523
 
Some Viagra Users Temporarily Lost Vision, New Reports Say
August 12, 1998 1:04 AM

By Rochelle Sharpe, Staff Reporter of The Wall Street
Journal

WASHINGTON -- Some men with cardiovascular
problems temporarily lost their vision after taking Viagra,
according to new reports about the impotence pill's side
effects.

One 58-year-old man who lost vision in his left eye after
taking Viagra had problems "indicative of vascular
occlusive disease," or clogged blood vessels, "unlike
anything (the doctor) had seen before," according to
reports collected by the Food and Drug Administration
that The Wall Street Journal obtained through the
Freedom of Information Act. Another man, who
suffered from high blood pressure, temporarily lost half
his vision in his right eye after taking the pill, the reports
said.

"It's impossible to know whether there's any relation to
Viagra," said Alan Laties, a consultant to Viagra
manufacturer Pfizer Inc. and an ophthalmology professor
at the University of Pennsylvania Medical School.

But the handful of eye reports touch on the potential
problems that can occur if men with cardiovascular
disease resume intercourse using Viagra. If these men
strain their hearts during sex, blood vessels anywhere in
their bodies could be stressed -- including in their eyes,
said Michael Marmor, an ophthalmology professor at
Stanford University. The eye problems are "the ocular
equivalent of having a small stroke or small heart attack,"
he said.

Pfizer has said that in clinical trials, about 3% of Viagra
users have reported temporarily seeing a bluish tinge
after taking the drug, and studies are continuing.
Ophthalmologists are concerned that the drug may
chemically affect the eye because the drug blocks an
enzyme found in the retina.

But none of the reports indicates that Viagra is having a
direct chemical effect on the eye, Dr. Marmor said.
"This complication is more likely to be a report of
patients' underlying cardiovascular disease," he said.

Mariann Capriano, a spokeswoman for Pfizer, said the
reports to the FDA are "anecdotes, not trends," and
pointed out that more than 25 million doses of the drug
have been dispensed since its launch this spring, with
relatively few eye problems.

Viagra sales remain high but have been dropping the
past few weeks. In the week ended July 31, a total of
95,135 new prescriptions were written and 79,384
were refilled. That is down from a peak this spring of
nearly 300,000 new and refilled prescriptions a week.

Copyright (c) 1998 Dow Jones & Company, Inc.

All Rights Reserved.

smartmoney.com